Published in Int J Radiat Oncol Biol Phys on November 01, 2005
Quality-of-life effects of prostate-specific antigen screening. N Engl J Med (2012) 7.21
Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. J Clin Oncol (2014) 1.13
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation. Clinicoecon Outcomes Res (2013) 0.84
A cost-effectiveness analysis of adjuvant chemoradiotherapy for resected gastric cancer. Gastrointest Cancer Res (2008) 0.82
What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. Appl Health Econ Health Policy (2014) 0.75
Radiation costing methods: a systematic review. Curr Oncol (2016) 0.75
Feasibility of using administrative claims data for cost-effectiveness analysis of a clinical trial. J Med Econ (2008) 0.75
External-beam radiation therapy should be given with androgen deprivation treatment for intermediate-risk prostate cancer: new confirmatory evidence. Asian J Androl (2011) 0.75
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol (2008) 5.04
Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer. J Clin Oncol (2014) 4.31
Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? J Clin Oncol (2007) 2.96
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Health-state utilities and quality of life in hepatitis C patients. Am J Gastroenterol (2003) 2.42
Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg (2007) 2.28
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol (2007) 2.03
A practical approach to evidence-based dentistry: IX: how to appraise and use an article about economic analysis. J Am Dent Assoc (2015) 1.99
Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience. Vaccine (2010) 1.91
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis. J Clin Oncol (2012) 1.90
Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res (2009) 1.89
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol (2013) 1.88
Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol (2009) 1.82
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology (2010) 1.80
The effect of English language proficiency on length of stay and in-hospital mortality. J Gen Intern Med (2004) 1.80
Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken) (2011) 1.79
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform (2007) 1.76
Exploring the potential of Web 2.0 to address health disparities. J Health Commun (2011) 1.72
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys (2007) 1.71
Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf (2011) 1.69
Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.61
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol (2010) 1.58
Utility-based Quality of Life measures in Alzheimer's disease. Qual Life Res (2006) 1.55
Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53
Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol (2006) 1.53
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.52
Prostate cancer early detection program recruitment methods and show rates in men at high risk. J Urol (2009) 1.48
Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol (2010) 1.45
Early prevention of pressure ulcers among elderly patients admitted through emergency departments: a cost-effectiveness analysis. Ann Emerg Med (2011) 1.43
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Med Care (2015) 1.41
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys (2013) 1.40
Acute appendicitis in young children: cost-effectiveness of US versus CT in diagnosis--a Markov decision analytic model. Radiology (2008) 1.39
Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol (2010) 1.34
Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol (2007) 1.28
Preventing pressure ulcers in long-term care: a cost-effectiveness analysis. Arch Intern Med (2011) 1.25
MDM2 as a predictor of prostate carcinoma outcome: an analysis of Radiation Therapy Oncology Group Protocol 8610. Cancer (2005) 1.24
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis. PLoS Med (2010) 1.19
Physicians' attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada. Can J Gastroenterol (2011) 1.18
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology (2004) 1.17
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. Value Health (2012) 1.16
Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population. Diabetes Care (2004) 1.15
Comparative economic analyses of patient safety improvement strategies in acute care: a systematic review. BMJ Qual Saf (2012) 1.14
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys (2011) 1.14
Cost effectiveness of screening immigrants for hepatitis B. Liver Int (2011) 1.12
A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med (2005) 1.12
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making (2012) 1.12
Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases. Am J Clin Oncol (2009) 1.09
Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. J Clin Epidemiol (2005) 1.09
Determinants of mortality in patients with severe blunt head injury. Arch Surg (2002) 1.08
Entertainment education for informed breast cancer treatment decisions in low-literate women: development and initial evaluation of a patient decision aid. J Cancer Educ (2006) 1.08
Estimation of utilities for chronic hepatitis C from SF-36 scores. Am J Gastroenterol (2005) 1.08
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis. Int J Radiat Oncol Biol Phys (2006) 1.08
Cost concerns of patients with cancer. J Oncol Pract (2013) 1.07
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials. J Clin Oncol (2006) 1.07
Health care costs associated with hepatitis C: a longitudinal cohort study. Can J Gastroenterol (2010) 1.07
Entertainment education for breast cancer surgery decisions: a randomized trial among patients with low health literacy. Patient Educ Couns (2010) 1.06
Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.06
Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Urology (2003) 1.04
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol (2002) 1.04
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.03
Pressure ulcer multidisciplinary teams via telemedicine: a pragmatic cluster randomized stepped wedge trial in long term care. BMC Health Serv Res (2014) 1.03
Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14. Int J Radiat Oncol Biol Phys (2006) 1.03
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer. Cancer (2012) 1.02
Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy. Can Urol Assoc J (2009) 1.01
Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy. Int J Cancer (2010) 1.00
Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer. Med Decis Making (2006) 1.00
Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma. Cancer (2006) 1.00
Health state utilities and quality of life in patients with hepatitis B. Can J Gastroenterol (2012) 0.97
Cost implications of new treatments for advanced colorectal cancer. Cancer (2009) 0.96
Risk of rash in cancer patients treated with vandetanib: systematic review and meta-analysis. J Clin Endocrinol Metab (2012) 0.96
GenePath: a system for inference of genetic networks and proposal of genetic experiments. Artif Intell Med (2003) 0.96
Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. Value Health (2010) 0.95
Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation. Contemp Clin Trials (2011) 0.95
Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol (2008) 0.94
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys (2007) 0.94
Content validity for dementia of three generic preference based health related quality of life instruments. Qual Life Res (2002) 0.93
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors. Cancer Chemother Pharmacol (2011) 0.93
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Mov Disord (2004) 0.93
Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination. Int J Radiat Oncol Biol Phys (2011) 0.93
Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck (2002) 0.93
Feasibility of internet-based health-related quality of life data collection in a large patient cohort. J Med Internet Res (2010) 0.92
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head Neck (2004) 0.92
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. Am J Clin Oncol (2016) 0.91
A review of interventions triggered by hepatitis A infected food-handlers in Canada. BMC Health Serv Res (2006) 0.91
The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. Arthritis Rheum (2003) 0.91
Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan. BMC Health Serv Res (2012) 0.91
Indications for interferon/ribavirin therapy in hepatitis C patients: findings from a survey of Canadian hepatologists. Can J Gastroenterol (2003) 0.91
Health technology assessment: a comprehensive framework for evidence-based recommendations in Ontario. Int J Technol Assess Health Care (2009) 0.90
Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancer. Clin Adv Hematol Oncol (2011) 0.90
Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimer's Disease Quality of Life Study. Am J Geriatr Psychiatry (2011) 0.90
Integration of prostate cancer clinical data using an ontology. J Biomed Inform (2009) 0.90
Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. Pharmacoeconomics (2008) 0.89
The role of external beam radiation and targeted therapy in thyroid cancer. Semin Radiat Oncol (2012) 0.89
Prescribing patterns for Alzheimer disease: survey of Canadian family physicians. Can Fam Physician (2006) 0.89
The half-cycle correction explained: two alternative pedagogical approaches. Med Decis Making (2008) 0.89
The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression. J Hepatol (2010) 0.89